Covance Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10,718

Employees

  • Latest Deal Type
  • Debt Refin.

  • Financing Rounds
  • 6

  • Investments
  • 19

Covance General Information

Description

Provider of contract research services intended to serve drug, medical device and diagnostics, crop protection and chemical industries. The company offers drug development, nonclinical safety assessment, bioanalytical service, clinical trial testing, toxicology, clinical trial management and other consulting services, providing end-to-end drug development support to a wide range of industries.

Contact Information

Website
www.covance.com
Formerly Known As
Corning Pharmaceutical Services, Corning Pharmaceutical Services Inc
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • 210 Carnegie Center
  • Princeton, NJ 08540
  • United States
+1 (609)
Primary Industry
Other Pharmaceuticals and Biotechnology
Parent Company
Nao Medical
Corporate Office
  • 210 Carnegie Center
  • Princeton, NJ 08540
  • United States
+1 (609)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Covance Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Covance‘s full profile, request access.

Request a free trial

Covance Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of contract research services intended to serve drug, medical device and diagnostics, crop protection and chemi
Other Pharmaceuticals and Biotechnology
Princeton, NJ
10,718 As of 2023

Wilmington, MA
 

West Lafayette, IN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Covance Competitors (26)

One of Covance’s 26 competitors is Charles River Laboratories International, a Formerly PE-Backed company based in Wilmington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Charles River Laboratories International Formerly PE-Backed Wilmington, MA
Inotiv Formerly PE-Backed West Lafayette, IN
Imaging Endpoints Corporation Scottsdale, AZ
Parexel International Private Equity-Backed Durham, NC
Atlant Clinical Corporate Backed or Acquired Moscow, Russia
You’re viewing 5 of 26 competitors. Get the full list »

Covance Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Covance Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Covance‘s full profile, request access.

Request a free trial

Covance Investments & Acquisitions (19)

Covance’s most recent deal was a Later Stage VC with Biomakers for . The deal was made on 15-Mar-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Biomakers 15-Mar-2023 Later Stage VC Discovery Tools (Healthcare)
snapIoT 02-Oct-2020 Merger/Acquisition Discovery Tools (Healthcare)
GlobalCare Clinical Trials 01-Jul-2020 Merger/Acquisition Clinics/Outpatient Services
RCRI 09-Apr-2019 Merger/Acquisition Consulting Services (B2B)
MI Bioresearch 07-Mar-2019 Merger/Acquisition Laboratory Services (Healthcare)
You’re viewing 5 of 19 investments and acquisitions. Get the full list »

Covance Exits (4)

Covance’s most recent exit was on 01-Jan-2010 from Covance (Specialist Pharmaceutical Clinical Business). The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Covance (Specialist Pharmaceutical Clinical Business) 01-Jan-2010 Completed
CellCarta 18-Dec-2008 Completed
Covance (Salt Lake City Bioanalytical Operations) 01-Jan-2008 Completed
Noveprim 01-Mar-2004 Corporate Completed
To view Covance’s complete exits history, request access »

Covance Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Covance Laboratories Pension Scheme Harrogate, United Kingdom

Covance FAQs

  • When was Covance founded?

    Covance was founded in 1996.

  • Where is Covance headquartered?

    Covance is headquartered in Princeton, NJ.

  • What is the size of Covance?

    Covance has 10,718 total employees.

  • What industry is Covance in?

    Covance’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Covance a private or public company?

    Covance is a Private company.

  • What is Covance’s current revenue?

    The current revenue for Covance is .

  • How much funding has Covance raised over time?

    Covance has raised $125M.

  • Who are Covance’s investors?

    Corning, Health Cloud Capital, and Laboratory Corporation of America have invested in Covance.

  • Who are Covance’s competitors?

    Charles River Laboratories International, Inotiv, Imaging Endpoints, Parexel International, and Atlant Clinical are some of the 26 competitors of Covance.

  • When was Covance acquired?

    Covance was acquired on 01-Jul-2001.

  • Who acquired Covance?

    Covance was acquired by Nao Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »